- Agriculture
- Art
- Anthropology
- Astronomy
- Biology
- Business
- Chemistry
- Classics
- Communications
- Computer Science
- Creative Writing
- Cultural Studies
- Dance
- Design
- Earth Sciences
- Economics
- Education
- Engineering
- English Studies
- Entertainment
- Ethnic Studies
- Gender Studies
- Geography
- Health
- History
- Journalism
- Law
- Library Science
- Linguistics
- Literature
- Mathematics
- Military Science
- Music
- Philosophy
- Physics
- Pharmacology
- Medicine
- Political Science
- Psychology
- Public Affairs
- Religious Studies
- Sociology
- Theatre
- Other
| Source Origin: Click here | Email this citation |
| Sandro Pignata Sabino Placido Rosalbino Biamonte et al. |
| 2006 January 7 |
| -------------------------------------------------------- |
| -------------------------------------------------------- |
| -------------------------------------------------------- |
| Electronic Source |
| Subject: Health | Publisher: BMC Cancer |
| Volume: 6 | Number: 5 |
| Page/Paragraph: NULL | Number of Volumes Cited: 1 |
| CiteNumber: 1064 | Contributor: jwalker |
| View URL: | Click here |
| -------------------------------------------------------- |
| Browse by: |
| Current Title Current Publisher Current Subject Current Contributor |
| Edit/Delete this Citation |
Citation Formatter
APA Style
Pignata, S., Placido, S., & Biamonte, R., etal. (2006). Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. BMC Cancer, 6(5). Retrieved September 5, 2010, from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1361775
MLA Style
Pignata, Sandro, Sabino Placido, and Rosalbino Biamonte, etal. ''Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.'' BMC Cancer 6.5 (2006). 5 September 2010 <http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1361775>.
Chicago Manual of Style
Pignata, Sandro, Sabino Placido and Rosalbino Biamonte, etal. ''Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.'' BMC Cancer 6, no. 5 (2006). http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1361775 (accessed September 5 2010).
Pignata, S., Placido, S., & Biamonte, R., etal. (2006). Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. BMC Cancer, 6(5). Retrieved September 5, 2010, from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1361775
MLA Style
Pignata, Sandro, Sabino Placido, and Rosalbino Biamonte, etal. ''Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.'' BMC Cancer 6.5 (2006). 5 September 2010 <http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1361775>.
Chicago Manual of Style
Pignata, Sandro, Sabino Placido and Rosalbino Biamonte, etal. ''Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.'' BMC Cancer 6, no. 5 (2006). http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1361775 (accessed September 5 2010).
